| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |